Treatment of Early-Stage, Node-Negative NSCLC When Surgery Is Not an Option

This protocol covers early-stage, node-negative non-small cell lung cancer (NSCLC) in patients who are medically inoperable, at high surgical risk, or who decline surgery — a clinical scenario where the treatment approach differs significantly from the standard surgical pathway.

Clinical Scenario

Patients may be candidates for this pathway if underlying medical conditions preclude safe surgery, if their functional status only allows a limited resection but not lobectomy (for example, due to advanced age, reduced lung reserve, or cardiac impairment), or if the patient refuses operative intervention. Node-negative, early-stage disease is confirmed prior to treatment planning.

Treatment Approach

Definitive radiation therapy — with a highly focused, ablative form of radiotherapy as the preferred option for eligible patients — is the primary strategy in this setting. For selected patients who are not candidates for that radiation approach, image-guided thermal ablation may be considered. The complete protocol specifies the decision pathway, patient selection criteria, and sequencing.

Full regimen details and selection criteria available in the structured protocol →

Instant Access to Structured Evidence-Based Regimens

References

Patients with medically inoperable early-stage NSCLC may be candidates for definitive RT, preferably SABR, also known as stereotactic body RT (SBRT).

SABR is also an appropriate option for patients with high surgical risk (able to tolerate sublobar resection but not lobectomy [eg, age ≥75 years, poor lung or cardiac function]).

Definitive RT, preferably SABR, is recommended for patients with early-stage NSCLC who are medically inoperable or those who refuse surgery.

Image-guided thermal ablation (eg, cryotherapy, microwave, RFA) is an option for selected patients who are medically inoperable and not receiving SABR or definitive RT.

View source ↗